My watch list  


Companies Vaccines


SIRION Biotech is Europe's leading commercial supplier of viral vectors used for genetic cell modelling, gene target validation and gene therapy- and vaccination studies. Since its foundation in 2007, SIRION’s mission has been to change the paradigm for viral vector supplies. It has the ability to more


VEROVACCiNES discovers and develops innovative vaccine solutions, to protect animals against infectious diseases. Key is a novel, broadly applicable, yeast-based technology to generate subunit marker vaccines. This technology has been validated by demonstrating protection of several target animal sp more

Virometix AG, Switzerland

Virometix AG is a privately held biotechnology company developing a new generation of vaccines and immunotherapeutic drugs for the prevention. In an increasingly global world there is a considerable medical need for vaccines to combat infectious as well as a number of chronic human diseases. Fast gr more

News Vaccines

  • 15 emerging technologies that could reduce global catastrophic biological risks

    Strategic investment in 15 promising technologies could help make the world better prepared and equipped to prevent future infectious disease outbreaks from becoming catastrophic events. This subset of emerging technologies and their potential application are the focus of a new report, Technologies more

  • Raman spectroscopy allows fast analysis of vaccines

    Vaccines are complex biomedicines composed of a number of different molecules. In the manufacturing process and before marketing authorisation, extensive research is required to verify the identity, quality, efficacy and safety of the products. Fast, cost-effective yet reliable analytical methods ar more

  • Taking out the (life-threatening) garbage

    Scientists have known for decades that certain bacteria produce small spherical versions of themselves. Although they lack basic materials to reproduce or function like normal cells, recent interest in such "minicells" has spiked due to their proficiency as nano-sized delivery tools for drugs and va more

All news on vaccines

Infographics Vaccines

A Summary of Common Vaccine Components

The recent measles outbreak in the US has once again provoked discussion over vaccinations, and why some parents choose not to vaccinate their children despite the benefits of doing so. Whilst not the only factor, part of the blame lies with misinformation about the chemical composition of vaccines more

Events Vaccines


Nonclinical Safety Evaluation of Preventive Vaccines

Advances in biotechnology have driven the development of vaccines beyond traditional inactivated whole cell organisms into novel protein polysaccharide conjugates, peptides, and recombinant proteins. This unconventional drug class, however, comes with its own set of challenges. Its sheer diversity r


Application of DSC to structural studies on meningitis vaccines

Neisseria meningitidis is the leading cause of bacteraemia and sepsis in children and young adults due to the non-specific nature of the initial symptoms and rapid progress of the infection. Vaccination is the best approach to protect individuals and progress has been made in their development. Howe


Development, Validation, and Implementation of GMP Release Potency Assays for Vaccines

The function of vaccines is to deliver antigens in order to induce an immune response and immune memory. Vaccines can be categorized according to either the method of antigen presentation or their intended use. Most vaccines are preventative, which induce long-term immune memory that can protect the

All events on vaccines

Publications Vaccines

All publications on vaccines

Market studies Vaccines

  • Vaccines - Senegal

    This market research report offers an in-depth perspective on the actual market situation, trends and future outlook for vaccines in Senegal. The analysis provides essential market information for decision-makers including:   * Overall market value for vaccines in Senegal * Overall market volume for more

  • iBio, Inc. (NYSE ) - Financial and Strategic SWOT Analysis Review

    iBio, Inc. (iBio, formerly iBioPharma, Inc.) is a biotechnology company, engaged in the development of vaccines and therapeutic proteins based on its plant-based iBioLaunch platform technology, which is used in the manufacture of biopharmaceuticals. Its products include influenza vaccines, biodefenc more

  • Iran Pharmaceuticals and Healthcare Report Q2 2012

    BMI View: We continue viewing Iran as one of the less attractive regional markets. Imposition of more stringent international sanctions, rampant inflation, and the loss of confidence in the Iranian rial weigh heavily on consumption and investment patterns, and also on government revenues and the aut more

All market studies on vaccines

Timeline of vaccines

Timeline of vaccines This is a timeline of the development of prophylactic human vaccine s. Early vaccines may be listed by the first year of development or testing, but later entries usually show the year the vaccine finished trials and became ... more


This is where you can add this topic to your personal favourites

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE